Spinomix will present at the Association for Laboratory Automation event held on January 26-30, 2008 in Palm Springs, CA its “MagPie™” system. MagPie™ is an integrated diagnostic instrument which uses MagPhase™ technology - an innovative method of minute manipulation of coated magnetic particles in a micro-fluidic environment. This technology opens new perspectives in standard magnetic particles based assays, through the integration of complex assay procedures, within a simple and easy to use miniaturized and automated system.
Tomas Svoboda, CEO of Spinomix said: “The MagPhase™ technology reached an important validation milestone late in 2007 using patient samples at the University Hospital of Geneva (HUG), Switzerland with the development of the rapid MagRSA test a scientific project sponsored and coordinated by the EU research program. We are confident that our integrated “MagPie™” instrument will rapidly find its place in the research and diagnostic market segments due to its compact size, ease of use and excellent price per performance ratio characteristics.”
Spinomix SA – is an early stage company based in Lausanne, Switzerland which develops innovative technologies for the biomolecular market with the intention to simplify many labor and cost intensive manipulations in molecular diagnostic and sample preparation. The company’s patent portfolio and close cooperation with three life science focused universities on lake Geneva provide an important spring board in this rapidly growing market segment.